Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99
スポンサーリンク
概要
著者
-
Wahren Britta
Department Of Virology Swedish Institute For Infectious Disease Control
-
Levi Michael
Department Of Virology Swedish Institute For Infectious Disease Control
-
Link H
Experimental Neurology Unit Division Of Neurology Karolinska Institutet Huddinge University Hospital
-
SHI Fu-dong
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
LINK Hans
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
LIU Jin-Qing
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
BAI Xue-Feng
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
XIAO Bao-Guo
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
LI Hu-Lun
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
MUSTAFA Maha
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
Bai Xue-feng
Division Of Neurology Karolinska Institute Huddinge University Hospital
-
Link Hans
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Shi Fu-dong
Microbiology And Tumor Biology Center (mtc) Karolinska Institutet
-
Liu Jin-qing
Division Of Neurology Karolinska Institute Huddinge University Hospital
-
Xiao Bao-guo
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Xiao Bao-guo
Division Of Neurology Karolinska Institute Huddinge University Hospital
-
Mustafa Maha
Division Of Neurology Karolinska Institute Huddinge University Hospital
関連論文
- Experimental autoimmune myasthenia gravis induction in B cell-deficient mice
- Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99
- Therapeutic potential of IFN-γ-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis
- Tumor necrosis factor receptor-1 is critically involved in the development of experimenetal autoimmune myasthenia gravis
- Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing gransforming growth factor-β-secreting cells and suppressing chemokine expression